	Metanephric Stromal Tumor of the Kidney in 9-year-old boy: Diagnostic Dilemma and Nephron-Sparing Approach. J Indian Assoc Pediatr Surg Prajapati P, Kumar T, Kumar B, Mathew P. PMID: 42312273 [PubMed]
	1H MR-based detection of human plasma metabolic alterations in clear cell renal cell carcinoma. BJUI Compass Sharma RK, Solaiyappan M, Feinaj A, Brönimann S, Singla N, Bhujwalla ZM, Ged Y. PMID: 42311813 [PubMed]
	Gold Nanoparticle Radiosensitization for High-Dose-Rate Brachytherapy: Differential Efficacy of PEG- and RGD-Functionalized Gold Nanoparticles Across 2-Dimensional, 3-Dimensional, and in vivo Prostate Cancer Models. Int J Nanomedicine Cecchi D, Jackson N, Karaman D, Beckham W, Johnstone CD, Lloyd SAM, Chithrani D. PMID: 42311423 [PubMed - indexed for MEDLINE]
	Liquid biopsy-guided kidney-sparing management in upper tract urothelial carcinoma: from preoperative risk stratification to perioperative surveillance. Front Oncol Yu D, Tang J, Zhang Y, Hu K, Qing J, Zhang J. PMID: 42311269 [PubMed]
	Prostate cancer research on social media platforms: a bibliometric and thematic analysis. Front Oncol Xie Y, Huang H, Chen X, Chen L, Guo Z. PMID: 42311243 [PubMed]
	MYC gene amplification drives protein overexpression and its clinical prognostic value in prostate cancer: a study of 152 Chinese cases. Am J Clin Pathol Tang M, Xie C, Huang R, Lei C, Yu X, Zhou P. PMID: 42310904 [PubMed - indexed for MEDLINE]
	AI-Assisted Prostate Cancer Diagnosis Using Biparametric MRI and PI-RADS v2.1: Performance Comparison Between Novice-Level and Experienced Readers. J Magn Reson Imaging Li K, Mi S, Chen L, Jiang M, Wang B, Huang Y, Wang Y, Fei G, Fu K. PMID: 42309979 [PubMed - as supplied by publisher]
	Comparison FT-IR spectral fingerprints of kidney Cancer in urine and serum: Clinical correlations and diagnostic potential. Spectrochim Acta A Mol Biomol Spectrosc Mitura P, Odrzywolski A, Gumbarewicz E, Godzisz M, Kuliniec I, Depciuch J. PMID: 42309029 [PubMed - as supplied by publisher]
	Assessment of Tumor Microenvironment Inflammatory Biomarkers in Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Clin Genitourin Cancer Drüke L, Schmitz J, Vicente MM, Vasileiadis N, Christensen D, Maulhardt M, Kuczyk MA, Tezval H, Darr C, Grünwald V, Ivanyi P, Bräsen JH. PMID: 42308960 [PubMed - as supplied by publisher]
	Quantitative Histogram Analysis of 5.0T Multiparametric MRI for Discrimination Between Prostate Cancer and Benign Hyperplasia. Technol Cancer Res Treat Zheng C, Xing S, Liu X, Xiang S, Xiong Y, Ma H, Emu Y, Zeng W. PMID: 42308481 [PubMed - indexed for MEDLINE]
	CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma. Technol Cancer Res Treat Ng CS, Chen Y, Wei W, Chandler AG, Hobbs BP, Tannir NM. PMID: 42308169 [PubMed - indexed for MEDLINE]
	Single-port robotic radical prostatectomy: early results from a UK centre. World J Urol McNicholas DP, Heslop CRA, Agarwal K, Dexter E, Weston R, Hanchanale V. PMID: 42307697 [PubMed - indexed for MEDLINE]
	Prostate Cancer - 20-Year Comparative Mortality and Survival Analysis by Age, Race/Ethnicity, Stage, Grade, Disease Duration and Cohort Entry Period: A Systematic Review of 648,114 cases for Diagnosis Years 1975-2022. J Insur Med Milano AF. PMID: 42307551 [PubMed - indexed for MEDLINE]
	Elevated serum Raftlin levels in non-muscle invasive bladder cancer: diagnostic implications and rs690037 genotype analysis. Rev Assoc Med Bras (1992) Balci S, Tanriverdi R, Nebio, Yildirim DD, Gülüm C, Bozlu M, Tamer L. PMID: 42307354 [PubMed - indexed for MEDLINE]
	Belzutifan in Von Hippel-Lindau Syndrome and Renal Cell Carcinoma: Mechanisms, Clinical Evidence, and Future Directions. Cureus Park J, Arshad H, Khan S, Vinod NP, Goel R, Vats D, Arshad I. PMID: 42306392 [PubMed]
	Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141]. Eur Urol Open Sci Bickley L, Fransen van de Putte EE, van den Brink L, Marandino L, van der Mijn JC, Wilgenhof S, van Thienen JV, Haanen JBAG, Boleti E, Powles T, Zondervan PJ, Graafland NM, Tippu Z, Turajlic S, Bex A. PMID: 42305796 [PubMed]
	Combining the PI-RADS v2.1 score with PSAD improves the diagnostic accuracy of transition zone prostate cancer. Arch Med Sci Zhong J, Ding J, Zhang Y, Yang Q. PMID: 42305309 [PubMed]
	First-in-human evaluation of [(18)F]-AlF-NOTA-neurotensin for NTSR1-targeted imaging of prostate cancer: a head-to-head comparison with [(68)Ga]Ga-PSMA-617. Ann Med He J, Wang Y, Tang W, Gao X, Cai Y, Tang Y, Hu S. PMID: 42304982 [PubMed - indexed for MEDLINE]
	Editorial Comment on to Investigate Disparities in Strategies for Low-Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer Database. Int J Urol Tohi Y, Merseburger AS, Sugimoto M. PMID: 42304637 [PubMed - in process]
	Kidney cancer burden in China from 1990 to 2023: A retrospective population-based observational study. J Int Med Res Bai Z, Wang S, Wang H, Wang Y, Huang G, Hou Y. PMID: 42304621 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 179082

Page 1 of 8955



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy